LivingGLP1
Study S002412

Department of Pharmacy, the Affiliated Hospital of Xuzhou Medical University

ClinicalTrials.gov record

Registration

Registration
NCT05037045
Study type
INTERVENTIONAL
Masking
NONE
Status
COMPLETED
Enrollment
338
Start
2019-01-10
Primary completion
2023-10-01
Lead sponsor
The Affiliated Hospital of Xuzhou Medical University
Conditions
Type 2 Diabetes Mellitus
Interventions
DRUG:GLP-1 receptor agonist
Results posted
FALSE
Individual participant data sharing
NO

Registered primary outcomes

  • Change from baseline HbA1c at 1 month [1 month after GLP-1 RA treatment]
  • Change from baseline FPG at 1 month [1 month after GLP-1 RA treatment]
  • Change from baseline PPG at 1 month [1 month after GLP-1 RA treatment]
  • Change from baseline serum lipids at 1 month [1 month after GLP-1 RA treatment]
  • Change from baseline HbA1c at 3 month [3 month after GLP-1 RA treatment]
  • Change from baseline FPG at 3 month [3 month after GLP-1 RA treatment]
  • Change from baseline PPG at 3 month [3 month after GLP-1 RA treatment]
  • Change from baseline serum lipids at 3 month [3 month after GLP-1 RA treatment]
  • Change from baseline HbA1c at 6 month [6 month after GLP-1 RA treatment]
  • Change from baseline FPG at 6 month [6 month after GLP-1 RA treatment]
  • Change from baseline PPG at 6 month [6 month after GLP-1 RA treatment]
  • Change from baseline serum lipids at 6 month [6 month after GLP-1 RA treatment]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.